Assay News and Research

RSS

Antibody response 18 months after SARS-CoV-2 infection in vaccinated and unvaccinated individuals

A new study assessed the dynamics of IgG titers over 18 months in patients who had recovered from COVID-19 infections during March 2020.

24 Jan 2022

Novel SARS-CoV-2 mutations reported in chronic HIV patients

A new study describes the emergence of new SARS-CoV-2 variants in three immunocompromised patients.

23 Jan 2022

Robust BNT162b2 vaccine-induced B and T-cell immunity against early SARS-CoV-2 variants

Researchers describe the state of adaptive immunity following vaccination with the Pfizer-BioNTech BNT162b2 COVID-19 vaccine.

23 Jan 2022

Paxlovid provides a glimpse into the future against SARS-CoV-2

A recent study reveals that nirmatrelvir is potent and effective against the SARS-CoV-2 Omicron variant.

23 Jan 2022

SARS-CoV-2 prevalence in bivalve mollusks from harvesting areas in Southern Italy

The goal of the current study was to collect data on the prevalence of SARS-CoV-2 in bivalve mollusks harvested in the Campania region using dd RT-PCR for the detection of low levels of virus in mollusk tissues.

21 Jan 2022

The tetrapeptide tuftsin effectively impairs the binding of SARS-CoV-2 S1 to ACE2

In their recent study posted to the preprint server bioRxiv*, the researchers from China have shown that tuftsin, a natural phagocytosis-stimulating peptide, can effectively impair the binding of SARS-CoV-2 spike S1 subunit to ACE2 receptor in a dose-dependent manner and therefore can be considered a potential drug against SARS-CoV-2 infection.

20 Jan 2022

Exploring the potential utility of calcium channel inhibitors in SARS-CoV-2 infection

In a new study, researchers discuss the role of calcium signaling pathways as targets of inhibition in potential new antiviral therapeutic pathways for SARS-CoV-2.

20 Jan 2022

The effect of different environmental conditions on the binding behavior of the S protein and RBD of SARS-CoV-2

Researchers investigated the binding behavior of spike protein and receptor-binding domain of SARS-CoV-2 under different environmental conditions.

20 Jan 2022

A novel assay for the rapid detection of SARS-CoV-2 variants

A new study discusses a new assay method designed by researchers to identify SARS-CoV-2 variants.

20 Jan 2022

Research shows a relationship between increased SARS-CoV-2 seroreactivity and antimalarial humoral immunity

Researchers investigate the cross-reactivity of the SARS-CoV-2 with pre-pandemic malaria-exposed sera samples collected from Cambodia.

19 Jan 2022

Novel antibody that targets the N-terminal domain of SARS-CoV-2 identified

A new study discusses the targeted discovery of NTD-reactive antibodies from an individual who had recovered from SARS-CoV-2 infection.

19 Jan 2022

Emerging nanomaterials-based biosensor for detecting SARS-CoV-2

A new study aimed to highlight the different smart and emerging nanomaterials used to detect SARS-CoV-2.

19 Jan 2022

Study reports of receptor-binding domain multimer capable of enhancing the immune response against SARS-CoV-2

Researchers have discovered a new way to induce immunity against the RBD.

19 Jan 2022

Improved SARS-CoV-2 surveillance testing with self-collected saliva

The findings from a recent study conducted in the United States suggest that combining saliva with a practical pooling protocol may open the door for easier surveillance testing for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), particularly in resource-limited settings.

18 Jan 2022

Assay News and Research

Antibody response 18 months after SARS-CoV-2 infection in vaccinated and unvaccinated individuals

Novel SARS-CoV-2 mutations reported in chronic HIV patients

Robust BNT162b2 vaccine-induced B and T-cell immunity against early SARS-CoV-2 variants

Paxlovid provides a glimpse into the future against SARS-CoV-2

SARS-CoV-2 prevalence in bivalve mollusks from harvesting areas in Southern Italy

The tetrapeptide tuftsin effectively impairs the binding of SARS-CoV-2 S1 to ACE2

Exploring the potential utility of calcium channel inhibitors in SARS-CoV-2 infection

The effect of different environmental conditions on the binding behavior of the S protein and RBD of SARS-CoV-2

A novel assay for the rapid detection of SARS-CoV-2 variants

Research shows a relationship between increased SARS-CoV-2 seroreactivity and antimalarial humoral immunity

Novel antibody that targets the N-terminal domain of SARS-CoV-2 identified

Emerging nanomaterials-based biosensor for detecting SARS-CoV-2

Study reports of receptor-binding domain multimer capable of enhancing the immune response against SARS-CoV-2

Improved SARS-CoV-2 surveillance testing with self-collected saliva

MD Anderson and Eisbach Bio collaborate to develop precision oncology drugs

New genomic signature can spot aggressive tumor cells from primary, untreated prostate cancers

Analyzing disease severity of SARS-CoV-2 Omicron variant using RNA dependent RNA polymerase target delay

Applications of bioconjugated nanomaterials in SARS-CoV-2 diagnostics

Exploring SARS-CoV-2 Omicron variant’s neutralizing capacity of booster vaccines

Seroepidemiologic surveys for assessment of the COVID-19 pandemic in Japan

Exploring Strategies for Targeting Kinases in Innate Immunity eBook

How Omics Technologies Are Transforming Biological Research and Drug Discovery

How microplastics and bacteria interact to drive antibiotic resistance

Single-cell proteomics: Revealing proteome diversity from cellular heterogeneity to non-canonical biology

Latest News